Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials

JS Aday, BD Heifets, SD Pratscher, E Bradley… - …, 2022 - Springer
Rationale Psychedelic research continues to garner significant public and scientific interest
with a growing number of clinical studies examining a wide range of conditions and …

Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review

Z Walsh, OM Mollaahmetoglu, J Rootman, S Golsof… - BJPsych …, 2022 - cambridge.org
Background In the past two decades, subanaesthetic doses of ketamine have been
demonstrated to have rapid and sustained antidepressant effects, and accumulating …

Psychedelic communitas: intersubjective experience during psychedelic group sessions predicts enduring changes in psychological wellbeing and social …

H Kettner, FE Rosas, C Timmermann… - Frontiers in …, 2021 - frontiersin.org
Background: Recent years have seen a resurgence of research on the potential of
psychedelic substances to treat addictive and mood disorders. Historically and …

Ethical and legal issues in psychedelic harm reduction and integration therapy

B Pilecki, JB Luoma, GJ Bathje, J Rhea… - Harm Reduction …, 2021 - Springer
Psychedelic-assisted therapy may represent an upcoming paradigm shift in the treatment of
mental health problems as recent clinical trials have demonstrated strong evidence of their …

The psychedelic renaissance in clinical research: a bibliometric analysis of three decades of human studies with psychedelics

A Hadar, J David, N Shalit, L Roseman… - … of psychoactive drugs, 2023 - Taylor & Francis
Psychedelics were used in the treatment of psychiatric conditions prior to their prohibition in
the late 1960s. In the past three decades, there is a revived research interest in the …

Therapeutic alliance and rapport modulate responses to psilocybin assisted therapy for depression

R Murphy, H Kettner, R Zeifman, B Giribaldi… - Frontiers in …, 2022 - frontiersin.org
Background: Across psychotherapeutic frameworks, the strength of the therapeutic alliance
has been found to correlate with treatment outcomes; however, its role has never been …

[HTML][HTML] A case of prolonged mania, psychosis, and severe depression after psilocybin use: implications of increased psychedelic drug availability

G Barber, CB Nemeroff… - American Journal of …, 2022 - Am Psychiatric Assoc
A 32-year-old woman presented for continuation of treatment in May 2021 with a chief
complaint of “cognitive dysfunction and severe reduced functionality.” Eight months before …

[HTML][HTML] The need for psychedelic-assisted therapy in the black community and the burdens of its provision

DT Smith, SC Faber, NCT Buchanan, D Foster… - Frontiers in …, 2022 - frontiersin.org
Psychedelic medicine is an emerging field that examines entheogens, psychoactive
substances that produce non-ordinary states of consciousness (NOSC). 3, 4 …

MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials …

THW Ching, MT Williams, JB Wang… - Journal of …, 2022 - journals.sagepub.com
Background: Limited ethnoracial diversity in previous±3, 4-
methylenedioxymethamphetamine-assisted therapy (MDMA-AT) trials for posttraumatic …

Psychedelic commercialization: A wide-spanning overview of the emerging psychedelic industry

JS Aday, BS Barnett, D Grossman… - Psychedelic …, 2023 - liebertpub.com
Background: In the wake of positive clinical trial outcomes of psychedelic-assisted
psychotherapy for the treatment of various psychiatric disorders, there has been an influx of …